SureTrader
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Biogen had a major disappointment recently regarding their

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Reyeton Member Profile
 
Followed By 11
Posts 641
Boards Moderated 0
Alias Born 04/13/13
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 5:49:32 PM
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference GlobeNewswire Inc. - 2/8/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 5:05:16 PM
Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results GlobeNewswire Inc. - 2/7/2018 7:00:00 AM
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and C... GlobeNewswire Inc. - 2/5/2018 7:00:00 AM
Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference GlobeNewswire Inc. - 1/24/2018 7:00:00 AM
Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical H... GlobeNewswire Inc. - 1/16/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2017 4:13:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2017 4:11:28 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/11/2017 5:17:35 PM
Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs GlobeNewswire Inc. - 12/11/2017 7:00:00 AM
Anavex Life Sciences Reports Newly Published Data on Alzheimer's Disease Research Demonstrate the Neuroprotective Features of... GlobeNewswire Inc. - 11/21/2017 7:00:00 AM
Anavex Life Sciences to Present at the 5th Annual Mental Health Parity Addiction Equity Act Business Roundtable in Washington... GlobeNewswire Inc. - 11/8/2017 7:00:00 AM
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clini... GlobeNewswire Inc. - 11/4/2017 3:30:00 PM
Greenbank Cap, Inc. (OTC Pink: GRNBF) Closes Private Placement as Shares Climb InvestorsHub NewsWire - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces Additional Data at The Michael J. Fox Foundation’s Parkinson's Disease Therapeutics Conferen... GlobeNewswire Inc. - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017 GlobeNewswire Inc. - 10/27/2017 8:52:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/26/2017 2:50:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/24/2017 12:06:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2017 6:47:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2017 9:47:41 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2017 11:07:52 AM
Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Pat... GlobeNewswire Inc. - 10/12/2017 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2017 5:18:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/5/2017 5:57:37 PM
Reyeton   Saturday, 08/12/17 07:31:33 PM
Re: tradeherpete post# 115235
Post # of 142319 
Biogen had a major disappointment recently regarding their anti-lingo drug expected to restore mylen. It seems possible they are waiting for the Plus patent before teaming with us. If the patent is broad enough and allows linking A273 with drugs other than aricept, it seems that's what will bring them on board with us, hopefully a sizable initial lump sum and 50/50 partnership for MS. Stranger things have happened.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist